RETRACTED: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
A Retraction of the Original Research article
Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
by Dobriyan, A., Gluck, I., Alon, E., Barshack, I., Yahalom, R., and Vered, M. (2021). Front. Oral. Health. 2:653104. doi: 10.3389/froh.2021.653104
The journal and Authors retract the 23 April 2021 article cited above for the following reason as provided by the Authors:
Following publication, the Authors were informed that they were not entitled to publish the raw data underlying the findings by the supplier of the analyzed drug.
Therefore, with the agreement of the Authors and the Chief Editor of the Oral Cancers specialty of Frontiers in Oral Health, the publication is being retracted.
Citation: Frontiers Editorial Office (2022) Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings. Front. Oral. Health 3:893486. doi: 10.3389/froh.2022.893486
Received: 10 March 2022; Accepted: 10 March 2022;
Published: 22 March 2022.
Approved by:
Ricardo D. Coletta, Campinas State University, BrazilCopyright © 2022 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org